KLTO

Klotho Neurosciences, Inc.

NASDAQ: KLTO · HEALTHCARE · BIOTECHNOLOGY

$0.52

+0.00% today

Updated 2026-07-08

Market cap

$56.66M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.30

Dividend yield

—

52W range

$0 – $1

Volume

3.3M

Market cap

$56.66M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.30

Dividend yield

—

52W range

$0 – $1

Volume

3.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.3

Quality

C+

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-13.4

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →253 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -13.43 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-1.09M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-1.11M	$-598593.00	$-707458.00	$-6.15M	$-2.90M
EPS	—	—	—	—	$-0.30
Free cash flow	$-284021.00	$-724981.00	$-460804.00	$-3.07M	$-1.09M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
KLTO	$56.66M	16	4.3	3.0	5.0	5.3	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	3.7	5.5	—	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-73.51%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-77.20%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	5.5	-15.43%	Buy

Smart narrative

Klotho Neurosciences, Inc. trades at $0.52. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -13.43, it sits in the distress.

Frequently asked questions

What is Klotho Neurosciences, Inc.'s stock price?

Klotho Neurosciences, Inc. (KLTO) trades at $0.52.

Is Klotho Neurosciences, Inc. overvalued?

Klotho Neurosciences, Inc. carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Klotho Neurosciences, Inc.'s Altman Z-Score is -13.43, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-198.30%

Beta2.24

50D MA$0.34

200D MA$0.65

Shares out0.11B

Float0.07B

Short ratio—

Avg volume3.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

KLTO vs LLY →KLTO vs JNJ →KLTO vs ABBV →Stock screener →